3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow ozanimod: new trials by email Literature Review of ozanimod trials Research Report on ozanimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease RPC1063 - Crohn's Disease | Phase 2 | Completed | Celgene | 69 | 2015-10-09 | 2021-01-22 |
| Efficacy and Safety Study of Ozanimod in Ulcerative Colitis Ozanimod, Placebo - Ulcerative Colitis | Phase 2 | Completed | Celgene | 199 | 2012-12-26 | 2021-05-19 |
| Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients Ozanimod, Placebo - Relapsing Multiple Sclerosis | Phase 2 / Phase 3 | Completed | Celgene | 258 | 2012-09-18 | 2021-02-11 |
Colitis, Ulcerative (1) · Crohn Disease (1)
Celgene (3)
Hungary (3) · Poland (3) · Ukraine (3) · United States (3) · Belgium (2) · Bulgaria (2) · Canada (2) · Greece (2) · Russia (2) · Australia (1) · Georgia (1) · Israel (1) · Italy (1) · Netherlands (1) · New Zealand (1)
AnnKatrin Petersen, MD (1) · Kanthi Kollengode, MD (1)
PMID 26879276, PMID 30043658, PMID 32553149, PMID 38568396, PMID 39018016, PMID 41677183